Status:
COMPLETED
Short Daily Versus Conventional Hemodialysis for COVID-19 Patients
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
COVID-19
Eligibility:
All Genders
Phase:
NA
Brief Summary
Treatment of dialysis patients involved with COVID-19 with short daily hemodialysis has been supposed to improve short term outcome. It is unclear if short daily dialysis would optimize mortality or I...
Detailed Description
investigators undertook a randomized trial in ESRD patients infected with COVID-19 to determine: 1) if short-daily hemodialysis is associated with a reduction in mortality and ICU admission in one wea...
Eligibility Criteria
Inclusion
- ESRD patients \>3months on hemodialysis admitted for COVID-19
Exclusion
- ESRD patients \<3 months on hemodialysis infected with COVID-19
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2021
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT05212675
Start Date
March 1 2021
End Date
August 30 2021
Last Update
January 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nooshin Dalili
Tehran, Iran